Background:
PET scan is a non-invasive, complex and expensive medical imaging technology that is normally used for the diagnosis and treatment of various diseases including lung cancer.
IJ Radiology
PET scan is a non-invasive, complex and expensive medical imaging technology that is normally used for the diagnosis and treatment of various diseases including lung cancer.
The purpose of this study is to assess the cost effectiveness of this technology in the diagnosis and treatment of non- small cell lung carcinoma (NSCLC) in Iran.
The main electronic databases including The Cochrane Library and Medline were searched to identify available evidence about the performance and effectiveness of technology. A standard decision tree model with seven strategies was used to perform the economic evaluation. Retrieved studies and expert opinion were used to estimate the cost of each treatment strategy in Iran. The costs were divided into three categories including capital costs (depreciation costs of buildings and equipment), staff costs and other expenses (including cost of consumables, running and maintenance costs). The costs were estimated in both IR-Rials and US-Dollars with an exchange rate of 10.000 IR Rials per one US Dollar according to the exchange rate in 2008.
The total annual running cost of a PET scan was about 8850 to 13000 million Rials, (0.9 to 1.3 million US$). The average cost of performing a PET scan varied between 3 and 4.5 million Rials (300 to 450US$). The strategies 3 (mediastinoscopy alone) and 7 (mediastinoscopy after PET scan) were more cost-effective than other strategies, especially when the result of the CT-scan performed before PET scan was negative.
The technical performance of PET scan is significantly higher than similar technologies for staging and treatment of NSCLC. In addition, it might slightly improve the treatment process and lead to a small level of increase in the quality adjusted life year (QALY) gained by these patients making it cost-effective for the treatment of NSCLC.
© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
FAYAZ-BAKHSH A, Alipour V. A Review on the Paper Entitled: “The Cost-Utility Analysis of PET-Scan in the Diagnosis and Treatment of Non-Small Cell Lung Carcinoma in Iran. I J Radiol. 2014;11(4):e93655. doi: https://doi.org/10.5812/iranjradiol.18738
Şimşek Veske N, Fatih Ceran I, Gunluoglu G, Zeki Gunluoglu M, Cengiz Seyhan E, et al. The Effect of PET/CT-Derived Parameters on the Prediction of Survival in Lung Cancer Patients. I J Radiol. 2024;21(1):e139822. doi: https://doi.org/10.5812/ijradiol-139822
Buyukdereli G, Aktar Y, Kara E, Uguz A, Sonmez H. Role of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Cytologically Indeterminate Thyroid Nodules. I J Radiol. 2016;13(1):e21186. doi: https://doi.org/10.5812/iranjradiol.21186
Faramarzi A, Daroudi R, Nahvijou A, Sari AA, Arab M, et al. Economic Evaluation of Treatments for Patients with Esophageal Cancer: A Systematic Review. Int J Cancer Manag. 2019;12(3):e86631. doi: https://doi.org/10.5812/ijcm.86631
Bakhshayeshkaram M. Role of Positron Emission Tomography–Computed Tomography in Pulmonary Neoplasms. I J Radiol. 2014;11(30th Iranian Congress of Radiology):e93645. doi: https://doi.org/10.5812/iranjradiol.21330
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):